Registration
STINSON LLP for ROKIT AMERICA INC.
Firm
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA approval of regenerative organ treatments.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN WILLDING New | — |
Medical/Disease Research/Clinical Labs MED
FDA approval of regenerative organ treatments.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN WILLDING New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ROKIT HEALTHCARE CO., LTD. | South Korea | South Korea | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.